Jin Yide, Fuller Laphalle, Carreno Manuel, Esquenazi Violet, Blomberg Bonnie B, Wei Yu-Tao, Ciancio Gaetano, Burke George W, Tzakis Andreas, Ricordi Camillo, Miller Joshua
Department of Surgery, University of Miami School of Medicine, Miami, FL 33136, USA.
Hum Immunol. 2002 Jul;63(7):567-75. doi: 10.1016/s0198-8859(02)00402-0.
We have previously demonstrated that bone marrow cells (BMC) inhibit the generation of autologous Epstein-Barr virus (EBV) -specific cytotoxic T lymphocytes (CTL). It was also observed that CD3(+) cells obtained after 7 days of culture in the presence of autologous BMC could be used as inhibitors of EBV-CTL generation. In the present study, we examined these BMC induced regulator CD3(+) T cells with respect to phenotype, function, and T-cell activation pathways. We also questioned if the CD3(+) regulatory cell function is mediated by their direct effect on peripheral T cells or on the ability of antigen presenting cells (APC) to stimulate peripheral T cells. To answer this, CD3(+) cells from peripheral blood lymphocytes (PBL) were cultured with either CD3-depleted BMC or with CD3-depleted PBL. The CD3(+) cells were then isolated with immunomagnetic beads, designated as T(BM) and T(PBL), and were compared in functional studies. There was an increase in the expression of CD25 on T(BM) cells. The T(BM) cells also expressed less CD122 and a decreased number of CD3 molecules per cell. Both T(BM) and T(PBL) cell populations responded to mitogen (PHA) to the same magnitude. However, when stimulated through the CD3 complex with anti-CD3 monoclonal antibody (mAb), the T(BM) cells had a significantly decreased response than did T(PBL). The addition of IL-2 to these latter cultures augmented, but could not fully restore, the response. Additionally, stimulation of T(BM) cells with allogeneic cells failed to produce cytotoxic T cells. These "anergized" T(BM) and "nonanergized" (control) T(PBL) cells were added as third-party cells to a CTL generating culture of autologous PBL stimulated with allogeneic cells. The T(BM) cells exhibited suppressor function and inhibited the generation of CTL, in contrast with T(PBL). The effect of T(BM) cells on direct and indirect antigen presentation pathways demonstrated that T(BM) primarily effected indirect, but not direct, alloantigen presentation. To further explore the cytoplasmic T-cell activation events that occurred after the coculture of the PBL T cells with BMC, the levels of zeta-associated protein 70 (ZAP70) and extracellular receptor-activated kinase (ERK) were determined. There was a decrease in ZAP70 levels in the T(BM), which correlated with its reduced expression of cell surface CD3 and the attenuated response to anti-CD3 mAb activation. However, the activity of ERK was equally expressed by T(BM) and T(PBL). It, therefore, appears that the culturing of peripheral T cells with (non-T) BMC anergizes these cells (which become refractory to stimulation through the T-cell receptors), and induces immune suppressor function. These in vitro observations may provide a mechanism by which infused donor BMC serve to downregulate T-cell immunity.
我们之前已经证明,骨髓细胞(BMC)可抑制自体EB病毒(EBV)特异性细胞毒性T淋巴细胞(CTL)的产生。还观察到,在自体BMC存在下培养7天后获得的CD3(+)细胞可作为EBV-CTL产生的抑制剂。在本研究中,我们从表型、功能和T细胞激活途径方面研究了这些BMC诱导的调节性CD3(+) T细胞。我们还质疑CD3(+)调节性细胞功能是由其对外周T细胞的直接作用介导,还是由其对抗抗原呈递细胞(APC)刺激外周T细胞的能力的作用介导。为了回答这个问题,将外周血淋巴细胞(PBL)中的CD3(+)细胞与去除CD3的BMC或去除CD3的PBL一起培养。然后用免疫磁珠分离CD3(+)细胞,分别命名为T(BM)和T(PBL),并在功能研究中进行比较。T(BM)细胞上CD25的表达增加。T(BM)细胞还表达较少的CD122,且每个细胞的CD3分子数量减少。T(BM)和T(PBL)细胞群体对丝裂原(PHA)的反应程度相同。然而,当用抗CD3单克隆抗体(mAb)通过CD3复合物刺激时,T(BM)细胞的反应明显低于T(PBL)。在这些后期培养物中添加IL-2可增强反应,但不能完全恢复反应。此外,用同种异体细胞刺激T(BM)细胞未能产生细胞毒性T细胞。将这些“无反应性的”T(BM)细胞和“非无反应性的”(对照)T(PBL)细胞作为第三方细胞添加到用同种异体细胞刺激的自体PBL的CTL产生培养物中。与T(PBL)相比,T(BM)细胞表现出抑制功能并抑制CTL的产生。T(BM)细胞对直接和间接抗原呈递途径的作用表明,T(BM)主要影响间接而非直接的同种异体抗原呈递。为了进一步探索PBL T细胞与BMC共培养后发生的细胞质T细胞激活事件,测定了ζ相关蛋白70(ZAP70)和细胞外受体激活激酶(ERK)的水平。T(BM)中ZAP70水平降低,这与其细胞表面CD3表达减少以及对抗CD3 mAb激活的反应减弱相关。然而,ERK的活性在T(BM)和T(PBL)中表达相当。因此,似乎外周T细胞与(非T)BMC共培养会使这些细胞无反应(对通过T细胞受体的刺激变得难治),并诱导免疫抑制功能。这些体外观察结果可能提供了一种机制,通过该机制注入的供体BMC可下调T细胞免疫。